Invasive and non-invasive evaluation of spontaneous arteriogenesis in a novel porcine model for peripheral arterial obstructive disease

Atherosclerosis

Volumn 167, Issue 1, 2003, Pages 33-43

  Buschmann, Ivo R ^a   Voskuil, Michiel ^b   Van Royen, Niels ^a,b   Hoefer, Imo E ^a   Scheffler, Klaus ^a   Grundmann, Sebastian ^a   Hennig, Jürgen ^a   Schaper, Wolfgang ^c   Bode, Christoph ^a   Piek, Jan J ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Animal model; Arteriogenesis; Hemodynamics; Peripheral arterial obstructive disease

Indexed keywords

PHOSPHATE; SODIUM CHLORIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTERIOGRAPHY; ARTERY BLOOD FLOW; ARTERY CATHETER; ARTERY CATHETERIZATION; ARTERY LIGATION; ARTERY PERFUSION; ARTICLE; ATHEROSCLEROSIS; COLLATERAL CIRCULATION; CONTROLLED STUDY; DATA ANALYSIS; FEMORAL ARTERY; FLOW RATE; IN VIVO STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PRESSURE MEASUREMENT; PRIORITY JOURNAL; SWINE; VASODILATATION; X RAY;

ANGIOGRAPHY; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; ARTERIOSCLEROSIS; COLLATERAL CIRCULATION; EVALUATION STUDIES; FEMALE; FEMORAL ARTERY; HEMODYNAMIC PROCESSES; LIGATION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MODELS, ANIMAL; PERIPHERAL VASCULAR DISEASES; PROBABILITY; SENSITIVITY AND SPECIFICITY; SWINE; SWINE, MINIATURE;

EID: 12244261650     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00389-1     Document Type: Article

References (30)

1. Maier W., Windecker S., Boersma E., Meier B. Evolution of percutaneous transluminal coronary angioplasty in Europe from 1992-1996. Eur. Heart J. 22:2001;1733-1740.
2. Zwart-van Rijkom J.E., van Hout B.A. Cost-efficacy in interventional cardiology; results from the EPISTENT study. Eur. Heart J. 22:2001;1476-1484.
3. Arras M., Ito W.D., Scholz D., Winkler B., Schaper J., Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J. Clin. Invest. 101:1998;40-50.
4. Buschmann I., Schaper W. The pathophysiology of the collateral circulation (arteriogenesis). J. Pathol. 190:2000;338-342.
5. Cai W., Vosschulte R., Afsah-Hedjri A., Koltai S., Kocsis E., Scholz D., Kostin S., Schaper W., Schaper J. Altered balance between extracellular proteolysis and antiproteolysis is associated with adaptive coronary arteriogenesis. J. Mol. Cell. Cardiol. 32:2000;997-1011.
6. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6:2000;389-395.
7. van Royen N., Piek J., Buschmann I., Hoefer I., Voskuil M., Schaper W. Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc. Res. 49:2001;543-553.
8. Casscells W., Speir E., Sasse J., Klagsbrun M., Allen P., Lee M., Calvo B., Chiba M., Haggroth L., Folkman J., et al. Isolation, characterization, and localization of heparin-binding growth factors in the heart. J. Clin. Invest. 85:1990;433-441.
9. Unger E.F., Banai S., Shou M., Lazarous D.F., Jaklitsch M.T., Scheinowitz M., Correa R., Klingbeil C., Epstein S.E. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am. J. Physiol. 266:1994;H1588-H1595.
10. Yang H.T., Yan Z., Abraham J.A., Terjung R.L. VEGF(121)- and bFGF-induced increase in collateral blood flow requires normal nitric oxide production. Am. J. Physiol. Heart Circ. Physiol. 280:2001;H1097-H1104.
11. Hoefer I.E., van Royen N., Buschmann I.R., Piek J.J., Schaper W. Time course of artehogenesis following femoral artery occlusion in the rabbit. Cardiovasc. Res. 49:2001;609-617.
12. Ito W.D., Arras M., Winkler B., Scholz D., Schaper J., Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ. Res. 80:1997;829-837.
13. Scholz D., Ito W., Fleming I., Deindl E., Sauer A., Wiesnet M., Busse R., Schaper J., Schaper W. Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch. 436:2000;257-270.
14. Buschmann I.R., Hoefer I.E., van Royen N., Katzer E., Braun-Dulleaus R., Heil M., Kostin S., Bode C., Schaper W. GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis. 159:2001;343-356.
15. Seiler C., Pohl T., Wustmann K., Hutter D., Nicolet P.A., Windecker S., Eberli F.R., Meier B. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation. 104:2001;2012-2017.
16. van Royen N., Hoefer I., Buschmann I., Heil M., Kostin S., Deindl E., Vogel S., Korff T., Augustin H., Bode C., Piek J.J., Schaper W. Exogenous application of transforming growth factor beta 1 stimulates arteriogenesis in the peripheral circulation. FASEB J. 16:2002;432-434.
17. Takeshita S., Isshiki T., Sato T. Increased expression of direct gene transfer into skeletal muscles observed after acute ischemic injury in rats. Lab. Invest. 74:1996;1061-1065.
18. Banai S., Jaklitsch M.T., Casscells W., Shou M., Shrivastav S., Correa R., Epstein S.E., Unger E.F. Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circ. Res. 69:1991;76-85.
19. Fujita M., Kihara Y., Hasegawa K., Nohara R., Sasayama S. Heparin potentiates collateral growth but not growth of intramyocardial endarteries in dogs with repeated coronary occlusion. Int. J. Cardiol. 70:1999;165-170.
20. Unger E.F., Banai S., Shou M., Jaklitsch M., Hodge E., Correa R., Jaye M., Epstein S.E. A model to assess interventions to improve collateral blood flow: continuous administration of agents into the left coronary artery in dogs. Cardiovasc. Res. 27:1993;785-791.
21. Wolf C., Cai W.J., Vosschulte R., Koltai S., Mousavipour D., Scholz D., Afsah-Hedjri A., Schaper W., Schaper J. Vascular remodeling and altered protein expression during growth of coronary collateral arteries. J. Mol. Cell. Cardiol. 30:1998;2291-2305.
22. Maxwell M.P., Hearse D.J., Yellon D.M. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc. Res. 21:1987;737-746.
23. Schaper W., Schaper J. Collateral circulation - heart, brain, kidney, limbs. 1993;Kluwer Academic Publishers, Boston.
24. Pouiseuille M. Recherches experimentales sur le mouvement des liquids dans les tubes de trés petits diametres, Des Seances de L'Académie des Sciences 1841;11:961-67, 1041-48.
25. Schaper W. Therapeutic arteriogenesis has arrived. Circulation. 104:2001;1994-1995.
26. Freedman S.B., Isner J.M. Therapeutic angiogenesis for ischemic cardiovascular disease. J. Mol. Cell. Cardiol. 33:2001;379-393.
27. Nakae I., Fujita M., Miwa K., Hasegawa K., Kihara Y., Nohara R., Miyamoto S., Ueda K., Tamaki S., Sasayama S. Age-dependent impairment of coronary collateral development in humans. Heart Vessels. 15:2000;176-180.
28. Swift M., Kleinman H., DiPietro L. Impaired wound repair and delayed angiogenesis in aged mice. Lab. Invest. 79:1999;1479-1487.
29. Weinsaft J.W., Edelberg J.M. Aging-associated changes in vascular activity: a potential link to geriatric cardiovascular disease. Am. J. Geriatr. Cardiol. 10:2001;348-354.
30. Unger E.F. Experimental evaluation of coronary collateral development. Cardiovasc. Res. 49:2001;497-506.